Evolv Technologies Holdings, Inc. — Q1 2022 Form 10-Q
Reporting period: Three months ended March 31, 2022; unaudited. Evolv sells AI-based weapons-detection systems through equipment sales and recurring subscription arrangements, with related services. Comparisons are with Q1 2021; the company’s July 2021 merger also makes year-over-year share-count comparisons less like-for-like.
Financial performance and liquidity
| Metric | Q1 2022 | Q1 2021 |
|---|---|---|
| Revenue | $8.7 million | $4.0 million |
| Gross profit / margin | $1.6 million / 18.7% | $1.0 million / 26.2% |
| Operating loss | $25.9 million | $9.1 million |
| Net loss | $14.6 million | $13.8 million |
| Operating cash flow | $(35.9) million | $(12.0) million |
| Cash, cash equivalents and restricted cash at period end | $271.5 million | $22.1 million |
- Revenue increased 118%: product revenue rose 108% to $5.2 million, subscription revenue 132% to $3.0 million, and service revenue 154% to $0.5 million.
- Product revenue had a gross loss of $0.4 million (negative 7% margin), versus $0.3 million gross profit in Q1 2021. Management cited raw-material purchase-price variances and scrap inventory costs. Subscription gross margin improved to 65% from 54%; service margin fell to 11% from 36% amid higher field-service costs.
- Operating expenses increased 170% to $27.5 million, led by sales and marketing ($12.1 million, up 227%) and general and administrative ($11.1 million, up 283%). Stock-based compensation was $5.2 million versus $1.1 million.
- Net loss widened modestly despite a much larger operating loss, partly because other income included $11.3 million of favorable fair-value changes in earn-out, contingent-share and public-warrant liabilities. These noncash gains are volatile and are not operating revenue.
- Operating cash use rose to $35.9 million, including working-capital investment—particularly inventory and prepaid deposits for equipment. Investing cash use was $1.0 million; financing provided $0.2 million. Cash and cash equivalents alone were $270.9 million, down from $307.5 million at year-end.
- Debt carrying value was $10.0 million, including $3.0 million current and $7.0 million noncurrent; the $10.0 million JPMorgan term loan is secured by company assets, including intellectual property. A separate revolving facility of up to $10.0 million was undrawn as described. Current assets were $307.2 million and current liabilities $23.3 million.
- Remaining performance obligations were $50.5 million, including $41.8 million of subscription revenue; this is not a guarantee of future revenue.
Changes, outlook and key risks
- Management expects continued operating losses while it invests in research and development, sales and marketing, and manufacturing capacity. It expects those expense categories to increase in 2022; no specific revenue, margin, or earnings guidance was provided.
- Management stated that available cash, together with expected cash generation, should fund operating and capital needs for at least 12 months from the report date, while noting that additional capital may be needed. Supply-chain challenges affected the quarter; management expected them to ease in the near future.
- Growth drivers cited include adoption of touchless screening, more installed Express units, channel partners, and recurring subscription revenue. Risks include adoption and competition, product pricing and costs, reliance on contract manufacturers, supply disruptions, customer concentration in a single solution, continued losses, and potential need for financing.
- Management adopted lease accounting standard ASC 842 on January 1, 2022, recognizing operating lease liabilities and right-of-use assets. The company also recorded an immaterial out-of-period adjustment relating to prior-year earn-out accounting; it said the adjustment was not material to the current or prior periods.
- Disclosure controls were deemed ineffective at March 31, 2022 because of material weaknesses in staffing and segregation of duties, period-end reporting, complex transactions, revenue recognition, payables and accruals, and IT controls. Remediation was underway; management said the weaknesses were not yet remediated.
- The company reported no current litigation and no material changes to its previously disclosed risk factors. It also noted possible additional sales and use tax liabilities in various jurisdictions.
Important facts for investors to verify
- Whether revenue growth converts into improved product economics and sustained gross-margin improvement, given the negative product margin this quarter.
- Whether cash burn and working-capital investment remain elevated as manufacturing and sales scale, and how long cash resources support the plan.
- Whether recurring subscription revenue and the reported performance obligations translate into collections and recognized revenue as expected.
- Progress in remediating the disclosed material weaknesses, including reliable revenue and complex-transaction accounting controls.
- The effects of fair-value liability remeasurement, stock-based compensation and potential dilution from options, warrants, earn-out shares and contingent shares.